Tag Archives: Seres Therapeutics Inc.

Healthcare stocks continue rise from the ashes as legislative uncertainties wane; sanity, fundamentals return.

Several Democratic presidential candidates have embraced “Medicare for all” as a rallying cry. Others are calling for a variety of healthcare reforms, such as lowering Medicare’s eligibility age from the… Read more »

Gut-check alert: Don’t take your microbiome for granted. Seriously! And some gut-wrenching stock picks.

The News: Last month it was quietly reported that scientists working on the gut microbiome have discovered and isolated more than 100 completely new species of bacteria from healthy people’s… Read more »

Health sector’s biggest winners & losers as of March 17, 2017

Seres Therapeutics Inc. (Nasdaq: MCRB) led advancing issues, soaring $2.71, or 29% for the week, to $12.04. The small microbiome-therapeutics platform company released its fourth-quarter results earlier Thursday (March 16,… Read more »